New 52 Week Low Today

Oncorus Inc ONCR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
14.11UNCH (UNCH)
Volume
1,202
Close
14.11quote price arrow up+0.20 (+1.44%)
Volume
353,970
52 week range
13.05 - 37.86

...

Loading . . .

KEY STATS

  • Open14.45
  • Day High14.81
  • Day Low13.05
  • Prev Close13.91
  • 52 Week High37.86
  • 52 Week High Date01/05/21
  • 52 Week Low13.05
  • 52 Week Low Date03/05/21
  • Market Cap361.50M
  • Shares Out25.62M
  • 10 Day Average Volume0.27M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-1.61
  • P/E (TTM)-8.78
  • Fwd P/E (NTM)-5.92
  • EBITDA (MRQ)-32.222M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Oncorus Inc News

There is no recent news for this security.

Latest ONCR News From Our Partners

QUOTE FINDER

Profile

MORE
Oncorus, Inc. is a clinical stage biopharmaceutical company focused on developing viral immunotherapies for cancer patients. The Company is leveraging its platforms to develop a pipeline of intratumorally and intravenously administered product candidates designed to selectively attack and kill tumor cells and stimulate multiple arms of the immune system against tumors. The Company is developing a differentiated portfolio of locally and systemically administered oncolytic...
Mitchell Finer Ph.D.
Chairman
Theodore Ashburn M.D. Ph.D.
President
Steve Harbin
Chief Operating Officer
John McCabe
Chief Financial Officer
Lorena Lerner
Vice President
Address
450 KENDALL STREET, 5TH FLOOR
Cambridge, MA
02142
United States